Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Labelled Study of Pregabalin in the Treatment of Neuropathic Pain in Cervical Myeloradiculopathy (Pregabalin and Radicular Pain Study (PARPS))

NCT01061697 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT01061697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01061697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Labelled Study of Pregabalin in the Treatment of Neuropathic Pain in Cervical Myeloradiculopathy (Pregabalin and Radicular Pain Study (PARPS))
Lead sponsor
Singapore General Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
April 30, 2010
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical spondylosis, cervical spondylotic myelopathy, cervical spondylotic radiculopathy